- Investing Ideas
- /
- Hong Kong Healthcare Global Supply Chain Shortage
Hong Kong Healthcare Global Supply Chain Shortage
Results
20
20 companies
Sinopharm Group
Market Cap: HK$58.4b
Engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China.
1099
HK$18.68
7D
2.8%
1Y
-17.3%
IVD Medical Holding
Market Cap: HK$14.8b
An investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally.
1931
HK$9.52
7D
6.0%
1Y
378.4%
160 Health International
Market Cap: HK$10.7b
160 Health International Limited wholesales and retails pharmaceutical and healthcare products in China.
2656
HK$35.70
7D
24.8%
1Y
n/a
YSB
Market Cap: HK$7.9b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$11.65
7D
23.5%
1Y
50.3%
Shanghai Pioneer Holding
Market Cap: HK$2.4b
An investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China.
1345
HK$2.06
7D
5.1%
1Y
-6.4%
ClouDr Group
Market Cap: HK$878.2m
Provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management.
9955
HK$1.40
7D
2.2%
1Y
-40.7%
Charmacy Pharmaceutical
Market Cap: HK$629.6m
Engages in the pharmaceutical distribution business in the People’s Republic of China.
2289
HK$5.83
7D
0%
1Y
-27.8%
Guanze Medical Information Industry (Holding)
Market Cap: HK$579.5m
An investment holding company, provides medical imaging solutions in the People’s Republic of China.
2427
HK$0.61
7D
-6.2%
1Y
19.6%
Sinco Pharmaceuticals Holdings
Market Cap: HK$394.4m
An investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China.
6833
HK$0.19
7D
-7.6%
1Y
-19.8%
China Health Group
Market Cap: HK$351.5m
An investment holding company, engages in the distribution and services of medical equipment and consumables in the People’s Republic of China.
673
HK$0.59
7D
35.6%
1Y
-21.3%
Tai United Holdings
Market Cap: HK$309.8m
An investment holding company, primarily invests in properties in the People’s Republic of China, the United States, the United Kingdom, Australia, and Belgium.
718
HK$0.061
7D
3.4%
1Y
-33.0%
Kingworld Medicines Group
Market Cap: HK$300.7m
An investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products.
1110
HK$0.50
7D
-5.7%
1Y
-13.8%
Yunnan Energy International
Market Cap: HK$269.9m
An investment holding company, distributes analytical and laboratory instruments, and life science equipment in the People’s Republic of China, rest of Asia, and internationally.
1298
HK$0.98
7D
0%
1Y
6.5%
Tycoon Group Holdings
Market Cap: HK$268.2m
An investment holding company, distributes and retails a suite of health and well-being related products in Mainland China, Hong Kong, Macau, Singapore, Malaysia, and internationally.
3390
HK$0.31
7D
0%
1Y
-91.6%
Universal Health International Group Holding
Market Cap: HK$190.1m
An investment holding company, distributes and retails drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People’s Republic of China.
2211
HK$1.75
7D
-5.9%
1Y
73.3%
Sinopharm Tech Holdings
Market Cap: HK$135.0m
An investment holding company, engages in trading of medical and related products in China.
8156
HK$0.21
7D
-3.2%
1Y
115.3%
Pa Shun International Holdings
Market Cap: HK$87.0m
An investment holding company, engages in the pharmaceutical distribution and manufacturing businesses in the People’s Republic of China.
574
HK$0.06
7D
11.1%
1Y
9.1%
Grand Brilliance Group Holdings
Market Cap: HK$86.4m
An investment holding company, engages in supplying of medical devices in Hong Kong.
8372
HK$0.11
7D
-1.9%
1Y
16.5%
New Ray Medicine International Holding
Market Cap: HK$66.0m
An investment holding company, engages in distribution and trading of pharmaceutical and related products in the People’s Republic of China.
6108
HK$0.39
7D
2.6%
1Y
-33.9%
Wanjia Group Holdings
Market Cap: HK$55.5m
An investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong.
401
HK$0.093
7D
16.3%
1Y
31.0%